BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
8.91
8.91
Range Annuel
6.00
11.31
Changement quotidien
-1.87%
Changement Mensuel
-1.11%
Evolution sur 6 mois
+25.85%
Changement Annuel
-17.88%
Clôture Précédente
9.0 8
Open
8.9 1
Low
8.9 1
High
8.9 1
Volume
277
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

Nouvelles